We are Sorry, This Page doesn't Exist

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Insider buying can be an encouraging si.....»»

Insider buying ca.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

This week has eight scheduled IPOs with three billion-dollar deals coming from the biotech, diagnostics, software and solar equipment industries, among others. Here's a rundown. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 7) read more.....»»

Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»

After the huge IPOs from AirBnB Inc (NASDAQ: ABNB) and DoorDash Inc (NYSE: DASH) last week, the week of December 13 takes a slight breather with only three IPOs scheduled and one potential blockbuster. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 6) 0 read more.....»»

Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) Dova Pharmaceuticals.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) read more.....»»

Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»

Biotech stocks rebounded in last week after declining modestly in the previous week. read more.....»»

For bi.....»»

U.S. IPO Week Ahead: A Biotech Wave Drives 7 IPOs While Slack Targets A Direct Listing.....»»

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. read more.....»»

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»

Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»